These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34361613)

  • 1. Effects of Nifedipine on Renal and Cardiovascular Responses to Neuropeptide Y in Anesthetized Rats.
    Bischoff A; Stickan-Verfürth M; Michel MC
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
    Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
    Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
    King PJ; Widdowson PS; Doods HN; Williams G
    J Neurochem; 1999 Aug; 73(2):641-6. PubMed ID: 10428060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.
    Bischoff A; Erdbrügger W; Smits J; Michel MC
    J Physiol; 1996 Sep; 495 ( Pt 2)(Pt 2):525-34. PubMed ID: 8887762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin may be involved in neuropeptide Y-induced diuresis, natriuresis, and calciuresis.
    Bischoff A; Rascher W; Michel MC
    Am J Physiol; 1998 Oct; 275(4):F502-9. PubMed ID: 9755121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
    J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender and hypertension interact to regulate neuropeptide Y receptor responsiveness.
    Bischoff A; Gerbracht A; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):173-80. PubMed ID: 10685873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y enhances potassium excretion by mechanisms distinct from those controlling sodium excretion.
    Bischoff A; Michel MC
    Can J Physiol Pharmacol; 2000 Feb; 78(2):93-9. PubMed ID: 10737671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.
    Zhang P; Qi YX; Yao QP; Chen XH; Wang GL; Shen BR; Han Y; Gao LZ; Jiang ZL
    PLoS One; 2015; 10(7):e0131124. PubMed ID: 26131716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal effects of neuropeptide Y.
    Bischoff A; Michel MC
    Pflugers Arch; 1998 Mar; 435(4):443-53. PubMed ID: 9446690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin inhibits the natriuretic effects of neuropeptide Y in anesthetized rats.
    Bischoff A; Limmroth V; Michel MC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):704-8. PubMed ID: 9694924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats.
    Xu X; Guo F; He Q; Cai X; Min D; Wang Q; Wang S; Tian L; Cai J; Zhao Y
    Neuropeptides; 2014 Apr; 48(2):97-105. PubMed ID: 24444822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
    Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
    Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Y1, Y2 and Y5 subtypes of the neuropeptide Y (NPY) receptor in rabbit kidney. Sensitivity of ligand binding to guanine nucleotides and phospholipase C inhibitors.
    Parker SL; Parker MS; Crowley WR
    Regul Pept; 1998 Sep; 75-76():127-43. PubMed ID: 9802402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized rats.
    Bischoff A; Stickan-Verfürth M; Michel MC
    Pflugers Arch; 1997 May; 434(1):57-62. PubMed ID: 9094256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y regulates rat renal tubular Na,K-ATPase through several signalling pathways.
    Ohtomo Y; Ono S; Zettergren E; Sahlgren B
    Acta Physiol Scand; 1996 Sep; 158(1):97-105. PubMed ID: 8876753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine.
    Czyborra C; Bischoff A; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Apr; 373(1):37-44. PubMed ID: 16521006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.